They postulated that C11orf95 may play a driving role in the development of these supratentorial ependymomas because it was found to be fused to other transcription factors such as Yap1 [18] leading to activation of alternative pathways other than NF-κB. The gene discussed is YAP1; the disease is ependymoma.